Genomic Expression

Genomic Expression's mission is to save lives and to make the delivery of healthcare more effective. The company helps doctors select the best drug for their patients, by leveraging it's clinically focused RNA sequencing technology called OneRNA. OneRNA can uniquely identify and quantify more than 34,000 RNA's in one assay and is currently undergoing beta testing by pharma companies and clinicians. Preliminary data suggests that the OneRNA assay may be suitable for determining response to the novel immune therapies including the PD1 checkpoint inhibitors.